Jacob Antrican, Author at NFCR - Page 2 of 2

Jacob Antrican

Research by NFCR Scientists Reveals New Insights into Treatment Resistance of Metastatic Breast Cancer

Oscillating expression of a key cancer gene may impact treatment approaches for patients NFCR-supported scientist Dr. Daniel Haber and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression in metastatic breast cancer that may contribute to disease progression and resistance to treatment experienced by many…...

Read more

Welcoming Alaska Airlines Mileage Plan

We are pleased to welcome Alaska Airlines Mileage Plan as the newest way to earn with Fly to Find a Cure.  Along with its Global Partners, Alaska Mileage Plan offers its members the ability to earn and redeem miles to over 800 destinations around the world.  With this new earning opportunity, you…...

Read more

Minor League Baseball and Play4TheCure

For the second year in a row, Play4TheCure and minor league baseball are teaming up this summer to raise money and awareness for cutting-edge cancer research. The program was started by National Foundation for Cancer Research (NFCR) Youth Ambassador Ally Minker....

Read more

Be Like Amos – Our 9 Year Old Philanthropist

The NFCR staff was touched by this very special donation. Read his story and share it freely with others. It made our day and we hope it makes yours as well. Meet Amos, our now famous, 9 year old Philanthropist: Less than one year ago, Amos’ father, Phil, experienced a…...

Read more

National Foundation for Cancer Research and KEW, Inc. announce a collaboration

National Foundation for Cancer Research and KEW, Inc. announce a collaboration to increase awareness of the value of genetic testing. Big Data comes to Cancer Care Choices.  #Research4aCure BETHESDA, Maryland (June 8, 2016)  – The National Foundation for Cancer Research (NFCR) and Kew, Inc, a private oncology services company based…...

Read more

Erik’s 50th Marathon

  Erik Seastead died on March 24, 2016, after a three-month battle with glioblastoma, among the most aggressive and deadly forms of brain cancer. We’ll miss his kindness and his love. He was a family man. He was a loving husband. He was a runner, and he was our runner. He…...

Read more

2016 Szent-Györgyi Prize for Progress in Cancer Research

Mary-Claire King, Ph.D. of University of Washington Awarded 2016 Szent-Györgyi Prize for Progress in Cancer Research (Bethesda, MD – January 21, 2016) The National Foundation forCancer Research (NFCR) announced today that Mary-Claire King, Ph.D., University of Washington professor of medicine (medical genetics) and genome sciences has been awarded the 2016 Szent-Györgyi…...

Read more